Fidelity Investments’s Design Therapeutics DSGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.21M | Buy |
951,198
+3,148
| +0.3% | +$10.6K | ﹤0.01% | 2321 |
|
|
2025
Q1 | $3.66M | Sell |
948,050
-3,832
| -0.4% | -$14.8K | ﹤0.01% | 2258 |
|
|
2024
Q4 | $5.87M | Buy |
951,882
+123,217
| +15% | +$760K | ﹤0.01% | 2100 |
|
|
2024
Q3 | $4.46M | Buy |
828,665
+747,649
| +923% | +$4.02M | ﹤0.01% | 2164 |
|
|
2024
Q2 | $271K | Buy |
81,016
+2,675
| +3% | +$8.96K | ﹤0.01% | 2930 |
|
|
2024
Q1 | $316K | Sell |
78,341
-671
| -0.8% | -$2.7K | ﹤0.01% | 2865 |
|
|
2023
Q4 | $209K | Buy |
79,012
+8,954
| +13% | +$23.7K | ﹤0.01% | 2950 |
|
|
2023
Q3 | $165K | Sell |
70,058
-567,712
| -89% | -$1.34M | ﹤0.01% | 2945 |
|
|
2023
Q2 | $4.02M | Sell |
637,770
-320,133
| -33% | -$2.02M | ﹤0.01% | 2121 |
|
|
2023
Q1 | $5.53M | Sell |
957,903
-161,634
| -14% | -$933K | ﹤0.01% | 2060 |
|
|
2022
Q4 | $11.5M | Buy |
1,119,537
+36,675
| +3% | +$376K | ﹤0.01% | 1835 |
|
|
2022
Q3 | $18.1M | Buy |
1,082,862
+55,922
| +5% | +$935K | ﹤0.01% | 1645 |
|
|
2022
Q2 | $14.4M | Sell |
1,026,940
-426
| -0% | -$5.96K | ﹤0.01% | 1791 |
|
|
2022
Q1 | $16.6M | Buy |
1,027,366
+27,366
| +3% | +$442K | ﹤0.01% | 1870 |
|
|
2021
Q4 | $21.4M | Hold |
1,000,000
| – | – | ﹤0.01% | 1796 |
|
|
2021
Q3 | $14.7M | Hold |
1,000,000
| – | – | ﹤0.01% | 1967 |
|
|
2021
Q2 | $19.9M | Hold |
1,000,000
| – | – | ﹤0.01% | 1850 |
|
|
2021
Q1 | $29.9M | Buy |
+1,000,000
| New | +$29.9M | ﹤0.01% | 1620 |
|